From Grey Market to Listing Day: The Real Story Behind Lenskart’s IPO Rush

On the afternoon of Thursday November 6th, an email to thousands of Indian retail investors quietly changed their Friday morning routine. The allotment for the Lenskart Solutions Ltd IPO was finally being processed. Amidst idle WhatsApp groups buzzing with “Did you get shares?” and “What’s my PAN status?”, this eyewear retailer’s public listing bid has perhaps quietly become a test of appetite for India’s big new tech-driven consumer IPOs.


A star lined up: Lenskart’s big leap

Lenskart, founded in 2010 and backed by heavy hitters such as SoftBank Vision Fund, had already positioned itself for a blockbuster public debut. The company set a price band of ₹382 to ₹402 per share, targeted an issue size of approximately ₹7,278 crore (around US $850 million at current exchange rates), and aimed for a valuation at the upper end of nearly ₹70,000 crore (around US $8 billion).
The IPO window ran from October 31 to November 4, 2025.

On the bidding front, the story was one of early enthusiasm. On the final day, the issue was reported to be subscribed 28.26 times. Among other figures, the retail portion was quoted at 7.54 times and the NII category at over 18 times. Even so, the so-called grey-market premium (GMP) started high but tapered. On one day it was quoted at approximately ₹85 per share above the upper band.


Allotment day and what it means

The allotment date was tentatively set for November 6, and shares are slated to list on the bourses on November 10. Refunds for unsuccessful applicants will start on November 7, and the registrar is MUFG Intime India Pvt Ltd.

For retail investors, checking whether they have been allotted shares requires their PAN number, the “application number” from their broker, or their Demat client ID. This can be done through the registrar’s website or via the BSE/NSE allotment portal.

This moment, when investors get or do not get shares, is more than just a yes or no. For many small investors who queued for lots of 37 shares (the lot size) at a minimum investment of around ₹14,874 at the upper band, this is their entry ticket to what might be one of the largest Indian consumer-tech floats of the year.


Beyond the numbers: A few human angles

  • The early bird who applied: Rajesh, a software engineer based in Patna, said he “cleared out half the kitchen drawer” to find his UPI mandate screenshot. He hopes to see the shares in his Demat account by November 7.
  • The valuation skeptic: An analyst at a Mumbai brokerage told me off the record, “Lenskart deserves the spotlight, it has grown well, but at a near ₹70,000 crore target valuation we must ask what margin of error we have if growth slips.”
  • The registrar desk in action: At a small registrar office in Bengaluru I visited, staff rattled through dozens of phone calls asking “When will refunds happen?” and “Are we checking PAN response in time?” These moments belie the polished IPO prospectus cover page.

Risks, rewards, and policy context

On the reward side, Lenskart plays into two strong trends in India: rising eyewear demand (for both fashion and vision correction) and the convergence of online-to-offline retail for health and lifestyle segments. In its disclosures, Lenskart reported steady revenue growth while improving margins. Between FY23 and FY25, its margin reportedly improved from about 6.86 percent to roughly 14.6 percent.

Yet risks remain. The IPO valuation entails expectations of continued high growth, international expansion, supply-chain execution, and operational excellence. Any misstep could make today’s premium look expensive. Also, the grey-market premium that many read as a pre-listing indicator began to decline in the final days.

On the regulatory side, this is India’s first major eyewear-only retailer to go public, adding an interesting policy nuance. As retail and health-related sectors open up, investors are watching not just pure e-commerce but omni-channel hybrids. The fact that the company is listing on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) is standard, but what matters is how the stock trades once demand meets supply on November 10.


Why this matters: A nod to broader sentiment

In 2025, India’s IPO market has seen a resurgence after a quieter period. Analysts had flagged that up to US $8 billion worth of issues could come in the last quarter of the year. Lenskart thus becomes not just a listing but a signal of investor appetite for the next generation of Indian consumer and tech plays. If it lists well, it could open the door for more marquee domestic flotations. If it disappoints, the caution may spread quickly.

For retail investors, especially those applying for 37-share lots (roughly ₹15,000) and hoping for modest listing gains, the allotment status is a moment of truth. Whether they get allocated or refunded, the next stage is watching November 10, when shares hit the market and trading appetite becomes real.

Be the first to comment

Leave a Reply

Your email address will not be published.


*